Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 9.24B P/E 40.55 EPS this Y 32.20% Ern Qtrly Grth 41.50%
Income 163.5M Forward P/E 50.85 EPS next Y 18.10% 50D Avg Chg -10.00%
Sales 787.97M PEG 2.63 EPS past 5Y - 200D Avg Chg 4.00%
Dividend N/A Price/Book 16.17 EPS next 5Y 25.00% 52W High Chg -21.00%
Recommedations 3.00 Quick Ratio 12.50 Shares Outstanding 37.54M 52W Low Chg 46.00%
Insider Own 1.20% ROA 8.68% Shares Float 37.48M Beta 0.88
Inst Own 98.73% ROE 24.73% Shares Shorted/Prior 1.83M/1.47M Price 252.23
Gross Margin 86.99% Profit Margin 20.75% Avg. Volume 563,770 Target Price 324.27
Oper. Margin 19.38% Earnings Date Aug 5 Volume 408,157 Change -2.90%
About ShockWave Medical, Inc.

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California. As of May 31, 2024, Shockwave Medical, Inc. operates as a subsidiary of Johnson & Johnson.

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
PUCKETT DAN Chief Financial Offi.. Chief Financial Officer Feb 05 Sell 230.7 3,229 744,930 21,005 02/06/24
PUCKETT DAN Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 229.92 3,406 783,108 27,732 02/02/24
Zacharias Isaac President, CCO President, CCO Jan 26 Sell 224.69 4,000 898,760 63,920 01/29/24
Zacharias Isaac President, CCO President, CCO Jan 26 Option 6.71 4,000 26,840 67,920 01/29/24
Godshall Douglas Evan President & CEO President & CEO Jan 16 Sell 217.93 10,000 2,179,300 141,057 01/18/24
Godshall Douglas Evan President & CEO President & CEO Jan 16 Option 3.42 10,000 34,200 151,057 01/18/24
Zacharias Isaac President, CCO President, CCO Jan 12 Option 5.37 17,921 96,236 63,920 01/17/24
WATKINS FRANK T Director Director Jan 08 Sell 198.09 2,000 396,180 4,532 01/10/24
WATKINS FRANK T Director Director Jan 08 Option 3.42 2,000 6,840 6,532 01/10/24
Godshall Douglas Evan President & CEO President & CEO Jan 05 Sell 200.05 10,000 2,000,500 141,057 01/08/24
Godshall Douglas Evan President & CEO President & CEO Jan 05 Option 3.42 10,000 34,200 151,057 01/08/24
WATKINS FRANK T Director Director Jun 20 Option 3.416 3,000 10,248 4,532 01/04/24
Zacharias Isaac President, CCO President, CCO Dec 26 Sell 192.5 4,000 770,000 41,606 12/28/23
Zacharias Isaac President, CCO President, CCO Dec 26 Option 6.71 3,458 23,203 45,606 12/28/23
Godshall Douglas Evan President & CEO President & CEO Dec 15 Sell 188.79 5,000 943,950 141,057 12/18/23
Godshall Douglas Evan President & CEO President & CEO Dec 15 Option 3.42 5,000 17,100 146,057 12/18/23
PUCKETT DAN Chief Financial Offi.. Chief Financial Officer Dec 08 Sell 173.88 200 34,776 28,784 12/11/23
Phung Trinh VP, Finance VP, Finance Dec 07 Sell 171.63 203 34,841 29,037 12/08/23
Zacharias Isaac President, CCO President, CCO Nov 27 Sell 173.58 4,000 694,320 43,868 11/28/23
Zacharias Isaac President, CCO President, CCO Nov 27 Option 6.71 3,777 25,344 47,868 11/28/23
WATKINS FRANK T Director Director Nov 20 Sell 173.11 3,000 519,330 1,532 11/21/23
WATKINS FRANK T Director Director Nov 20 Option 3.42 3,000 10,260 4,532 11/21/23
Godshall Douglas Evan President & CEO President & CEO Nov 15 Sell 174.38 5,000 871,900 136,057 11/17/23
Godshall Douglas Evan President & CEO President & CEO Nov 15 Option 3.42 5,000 17,100 141,057 11/17/23
Phung Trinh VP, Finance VP, Finance Apr 26 Option 3.42 2,400 8,208 31,095 11/03/23
Zacharias Isaac President, CCO President, CCO Oct 26 Sell 210.25 4,000 841,000 44,316 10/30/23
Zacharias Isaac President, CCO President, CCO Oct 26 Option 6.71 411 2,758 48,316 10/30/23
WATKINS FRANK T Director Director Oct 20 Sell 203.14 3,000 609,420 1,532 10/23/23
WATKINS FRANK T Director Director Oct 20 Option 3.42 3,000 10,260 4,532 10/23/23
Godshall Douglas Evan President & CEO President & CEO Oct 16 Sell 199.71 10,000 1,997,100 141,649 10/17/23
Godshall Douglas Evan President & CEO President & CEO Oct 16 Option 3.42 10,000 34,200 151,649 10/17/23
Zacharias Isaac President, CCO President, CCO Sep 26 Sell 192.12 4,000 768,480 47,905 09/27/23
WATKINS FRANK T Director Director Sep 20 Sell 209.23 3,000 627,690 1,532 09/21/23
WATKINS FRANK T Director Director Sep 20 Option 3.42 3,000 10,260 4,532 09/21/23
Godshall Douglas Evan President & CEO President & CEO Sep 15 Sell 212.62 10,000 2,126,200 141,649 09/19/23
Godshall Douglas Evan President & CEO President & CEO Sep 15 Option 3.42 10,000 34,200 151,649 09/19/23
Phung Trinh VP, Finance VP, Finance Aug 29 Option 3.416 5,000 17,080 25,986 08/31/23
Zacharias Isaac President, CCO President, CCO Aug 25 Sell 204.98 4,000 819,920 52,446 08/29/23
Godshall Douglas Evan President & CEO President & CEO Aug 24 Sell 212.95 10,000 2,129,500 141,649 08/25/23
Godshall Douglas Evan President & CEO President & CEO Aug 24 Option 3.42 10,000 34,200 151,649 08/25/23
FRANCIS LAURA Director Director Aug 22 Sell 220.97 497 109,822 3,054 08/23/23
WATKINS FRANK T Director Director Aug 21 Sell 218.97 3,000 656,910 1,532 08/22/23
WATKINS FRANK T Director Director Aug 21 Option 3.42 3,000 10,260 4,532 08/22/23
Toyloy Sara Director Director Aug 15 Sell 223.64 100 22,364 3,673 08/16/23
Zacharias Isaac President, CCO President, CCO Jul 26 Sell 268.06 4,000 1,072,240 56,678 07/27/23
WATKINS FRANK T Director Director Jul 20 Sell 267.11 3,000 801,330 1,532 07/21/23
WATKINS FRANK T Director Director Jul 20 Option 3.42 3,000 10,260 4,532 07/21/23
Papiernik Antoine Director Director Jul 05 Option 17.00 17,381 295,477 22,662 07/06/23
Zacharias Isaac President, CCO President, CCO Jun 26 Sell 291.84 4,000 1,167,360 60,678 06/26/23
Phung Trinh VP, Finance VP, Finance Jun 22 Sell 295.91 62 18,346 21,101 06/26/23